High-throughput
바이오 프로세싱

미생물 배양 온라인 모니터링 시스템

이제 누구나, 언제든, 원하는 Cell을
Sorting 할 수 있습니다

CytoFLEX SRT의 자동화된 Cell sorting 기술을 확인해 보세요

Better + Together

Tip-Based and Acoustic Tip-Less Liquid Handling Integrated Workstations

Learn more about our Scalable Liquid Handling Solutions

PCR Cleanup과 Plasmid prep의
Next Generation Technology!

EMnetik system은 24개 샘플 처리에 단 16분이면 충분합니다

벡크만쿨터 라이프사이언스

벡크만쿨터는 1935년 창업 이후, 고객의 연구에 한결같이 임하고 있습니다. 80년 이상 동안 벡크만쿨터는 연구자들에게 신뢰할 수 있는 파트너로서 과학적 연구에 공헌해왔습니다. 벡크만쿨터 라이프사이언스는 생명과학 연구자, 제조 및 환경 분야의 기술자, 제약, 생물의학 과학자를 위한 글로벌 자원입니다. 

Learn more

Latest news & updates

Press Release

Beckman Coulter Life Sciences Achieves Industry-First Reagent Certification to Help Prepare Labs for IVDR and to Clear Confusion

INDIANAPOLIS – (April 17, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR.

Read more
Press Release

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Read more
Press Release

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes in developing and commercializing IVD & RUO NGS testing solutions that help research to optimize selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring.  

Read more